INTS
Intensity Therapeutics, Inc.Company with tickers: INTS
CIK
1567264
CUSIP
45828J202
Shares Outstanding
2,702,820
13F Activity (30d)
10 filings
10 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $3,394,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $2,189,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-3,394,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-3,347,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-5.51 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-5.51 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |